PathAI

PathAI is dedicated to improving patient outcomes with AI-powered pathology, providing tools for biomarker discovery, drug development, and laboratory workflow improvement. Its flagship product, AISight®, is a cloud-native digital pathology image management system used by leading laboratories and research centers. PathAI has received FDA clearance for AISight® Dx for primary diagnosis and has entered into a definitive merger agreement to be acquired by Roche to transform AI-driven diagnostics.

‍